GlassScriptPhysician profile
Ricky A Paul
NPI 1073699500
$23,724.18
in general payments reported to CMS, 2019-2025
39 companies · $983 in 2025
The $983 reported for 2025 was more than what 90% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32.47 · 2020: $1,791 · 2021: $7,845 · 2022: $1,150 · 2023: $11K · 2024: $697 · 2025: $983.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,029 · Food and Beverage: $3,733 · Travel and Lodging: $2,122 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,028.50 |
| Food and Beverage | $3,732.50 |
| Travel and Lodging | $2,122.17 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $18,665.35 | 2020-2024 | Davinci Xi, Da Vinci Surgical System |
| Daiichi Sankyo INC. | $682.77 | 2021-2025 | Injectafer |
| Abbvie INC. | $560.98 | 2019-2024 | |
| Hologic Sales and Service, LLC | $375.48 | 2021-2025 | Myosure Tissue Removal Device, Novasure, Aptima |
| Evofem Biosciences, INC. | $260.28 | 2021-2023 | Phexxi |
| Sage Therapeutics, LLC | $246.79 | 2022-2025 | Zurzuvae |
| Shield Therapeutics INC | $234.20 | 2022-2025 | Accrufer |
| Astellas Pharma US INC | $228.19 | 2023-2025 | Veozah |
| Avion Pharmaceuticals | $214.60 | 2021-2023 | Balcoltra |
| Bayer Healthcare Pharmaceuticals INC. | $185.66 | 2021-2024 | |
| Pfizer INC. | $185.34 | 2021-2025 | |
| Coopersurgical, INC. | $184.28 | 2021-2025 | Summit Doppler, Mara Console, Ally II Ups |
| Aspira Women'S Health INC | $148.08 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $144.36 | 2022-2025 | |
| Organon LLC | $137.59 | 2021-2025 | Nexplanon |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $129.16 | 2023-2024 | Myfembree |
| Coloplast Corp | $124.41 | 2022-2025 | |
| Caldera Medical, INC | $106.51 | 2023 | Desara |
| Lupin INC. | $96.82 | 2020-2021 | |
| Davol INC. | $91.67 | 2021-2024 | Arista Ah Flexitip |
| Exeltis, USA INC. | $88.82 | 2021-2025 | Slynd |
| Novo Nordisk INC | $63.64 | 2023-2024 | Wegovy |
| Conmed Corporation | $61.11 | 2023 | Airseal |
| Myriad Women'S Health, INC. | $57.46 | 2023 | Myrisk |
| Lilly USA, LLC | $52.43 | 2025 | Zepbound, Mounjaro |
| Amgen INC. | $48.09 | 2022-2023 | Evenity, Prolia |
| Ethicon US, LLC | $41.18 | 2021-2022 | |
| Smith+Nephew, INC. | $36.64 | 2022-2025 | Pico |
| Axsome Therapeutics, INC. | $34.97 | 2022-2025 | Auvelity |
| Scynexis, INC. | $33.05 | 2022 | |
| Dexcom, INC. | $29.09 | 2025 | Dexcom G6 Transmitter |
| Currax Pharmaceuticals LLC | $28.90 | 2019-2023 | Contrave |
| Supernus Pharmaceuticals, INC. | $24.65 | 2025 | Qelbree |
| Merck Sharp & Dohme LLC | $22.74 | 2021 | |
| Innovation Technologies INC | $22.32 | 2025 | Irrisept |
| Becton, Dickinson and Company | $22.11 | 2022 | |
| Axonics, INC. | $21.79 | 2023 | Bulkamid |
| Vertex Pharmaceuticals Incorporated | $17.90 | 2025 | |
| Myovant Sciences INC. | $14.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ricky Paul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.